Because only full-length CD74 can interact with APP48, an increased expression of cathepsin S in the AD cortex could deplete the full-length CD74, thereby cancelling the suppression of Aβ production and rather activating NF-κB. Here, NFKB1 is linked to Alzheimer disease.